Spots Global Cancer Trial Database for stage ia ovarian cancer ajcc v6 and v7

Every month we try and update this database with for stage ia ovarian cancer ajcc v6 and v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer	NCT03902379	Endometrial Car... Stage 0 Fallopi... Stage I Fallopi... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage II Cervic... Stage II Fallop... Stage II Ovaria... Stage II Uterin... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage III Cervi... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage III Uteri... Stage IIIA Cerv... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Internet-Based ... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer	NCT03902379	Endometrial Car... Stage 0 Fallopi... Stage I Fallopi... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage II Cervic... Stage II Fallop... Stage II Ovaria... Stage II Uterin... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage III Cervi... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage III Uteri... Stage IIIA Cerv... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Internet-Based ... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer	NCT00954174	Mixed Mesoderma... Ovarian Carcino... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IA Uterin... Stage IB Fallop... Stage IB Ovaria... Stage IB Uterin... Stage IC Fallop... Stage IC Ovaria... Stage IC Uterin... Stage II Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Uteri... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Uteri... Stage IIC Fallo... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	Carboplatin Ifosfamide Paclitaxel Quality-of-Life...	18 Years -	GOG Foundation
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer	NCT01081262	Borderline Ovar... Ovarian Mucinou... Recurrent Fallo... Recurrent Ovari... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIC Fall... Stage IIIC Ovar... Stage IV Fallop... Stage IV Ovaria...	Bevacizumab Capecitabine Carboplatin Laboratory Biom... Oxaliplatin Paclitaxel Quality-of-Life...	18 Years -	National Cancer Institute (NCI)
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer	NCT01081262	Borderline Ovar... Ovarian Mucinou... Recurrent Fallo... Recurrent Ovari... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIC Fall... Stage IIIC Ovar... Stage IV Fallop... Stage IV Ovaria...	Bevacizumab Capecitabine Carboplatin Laboratory Biom... Oxaliplatin Paclitaxel Quality-of-Life...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: